Question

When pharmaceutical firms are reluctant to develop new products because of major risks of trouble, it is referred to as _____.

A. causal ambiguity

B. nonstandard risk

C. drug lag

D. medical eclipse

Answer

This answer is hidden. It contains 195 characters.